NasdaqGM - Delayed Quote USD

Evolus, Inc. (EOLS)

9.19
-0.15
(-1.61%)
At close: May 30 at 4:00:00 PM EDT
9.28
+0.09
+(0.98%)
After hours: May 30 at 6:49:07 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
275,463
266,274
202,085
148,616
99,673
Cost of Revenue
87,007
83,970
64,514
58,842
43,534
Gross Profit
188,456
182,304
137,571
89,774
56,139
Operating Expense
221,368
209,539
182,547
149,349
119,754
Operating Income
-32,912
-27,235
-44,976
-59,575
-63,615
Net Non Operating Interest Income Expense
-14,992
-15,472
-12,972
-8,978
-1,395
Other Income Expense
-7,610
-7,049
-3,561
-5,764
18,242
Pretax Income
-55,514
-49,756
-61,509
-74,317
-46,768
Tax Provision
689
664
176
95
42
Net Income Common Stockholders
-56,203
-50,420
-61,685
-74,412
-46,810
Diluted NI Available to Com Stockholders
-56,203
-50,420
-61,685
-74,412
-46,810
Basic EPS
-0.89
-0.81
-1.08
-1.33
-0.94
Diluted EPS
-0.89
-0.81
-1.08
-1.33
-0.94
Basic Average Shares
63,241.68
62,016.85
56,918.72
56,065
49,773
Diluted Average Shares
63,241.68
62,016.85
56,918.72
56,065
49,773
Total Operating Income as Reported
-40,661
-34,411
-49,233
-65,330
-44,405
Total Expenses
308,375
293,509
247,061
208,191
163,288
Net Income from Continuing & Discontinued Operation
-56,203
-50,420
-61,685
-74,412
-46,810
Normalized Income
-56,203
-50,420
-61,685
-74,412
-64,718.36
Interest Income
3,456
3,263
860
119
1
Interest Expense
18,448
18,735
13,832
9,097
1,396
Net Interest Income
-14,992
-15,472
-12,972
-8,978
-1,395
EBIT
-37,066
-31,021
-47,677
-65,220
-45,372
EBITDA
-30,777
-25,001
-41,810
-60,723
-39,058
Reconciled Cost of Revenue
83,238
80,292
60,825
55,112
42,842
Reconciled Depreciation
6,289
6,020
5,867
4,497
6,314
Net Income from Continuing Operation Net Minority Interest
-56,203
-50,420
-61,685
-74,412
-46,810
Total Unusual Items Excluding Goodwill
--
--
--
0
24,532
Total Unusual Items
--
--
--
0
24,532
Normalized EBITDA
-30,777
-25,001
-41,810
-60,723
-63,590
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
6,623.64
12/31/2021 - 2/8/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

HROW Harrow, Inc.
28.11
+3.35%
 
ANIK Anika Therapeutics, Inc.
11.15
-0.98%
 
ETON Eton Pharmaceuticals, Inc.
18.89
-0.16%
 
SBBC.V TRUBAR Inc.
0.9200
-3.16%
 
KNSA Kiniksa Pharmaceuticals International, plc
27.36
+0.66%
 
TXMD TherapeuticsMD, Inc.
1.4600
-1.35%
 
LNTH Lantheus Holdings, Inc.
75.56
+0.05%
 
LFCR Lifecore Biomedical, Inc.
6.77
-1.17%
 
ANIP ANI Pharmaceuticals, Inc.
58.72
+0.79%
 
DERM Journey Medical Corporation
8.06
-0.12%